Released: June 2, 2011

CDMRP Lung Cancer Research Program
Funding Opportunities for Fiscal Year 2011

The Department of Defense Lung Cancer Research Program's (LCRP) vision is to eradicate deaths from lung cancer to better the health and welfare of the military and the American public. This program is administered by the US Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

The information in this pre-announcement is being provided to allow investigators time to plan and develop applications if funds become available. This pre-announcement should not be construed as an obligation by the government.

Award Mechanism Eligibility Key Mechanism Elements Funding
Concept Award Investigators at all academic levels (or equivalent)
  • Supports highly innovative, untested, potentially groundbreaking concepts in lung cancer
  • Emphasis is on innovation
  • Presentation of preliminary data is not consistent with the intent of the Concept Award mechanism and is discouraged
  • Human subject studies are permitted provided the studies are exempt or eligible for expedited review
  • Maximum funding of $75K for direct costs (plus indirect costs)
  • Maximum period of performance is 1 year

All applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the website. The application package will be made available on the website if funds become available.

A pre-application is required and must be submitted through the CDMRP eReceipt website ( prior to full application submission. A listing of all USAMRMC funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420.

Requests for email notification of the release of program announcements may be sent to For more information about the LCRP or other CDMRP-sponsored programs, please visit the CDMRP website (

Point of Contact: